A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors

J. Marshall, H. Chen, D. Yang, M. Figueira, K. B. Bouker, Y. Ling, M. Lippman, S. R. Frankel, D. F. Hayes

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint Dive into the research topics of 'A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences